USOR 24321 - Ph3 study to compare the combo in Golca+R with follicular lymphoma

A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator’s Choice in Participants with Relapsed/Refractory Follicular Lymphoma

Disease Types: Lymphoma

Available at: Arlington Heights, Chicago, Niles